Find the exact product record
Use the destination country's official medical-product directory or medicine register. Match the product, responsible holder, form, strength, status, and any available public documents.
Middle East and Africa / 5 country guides
Peptides in the Middle East and Africa: verify the product and licensed supplier first.
This Middle East and Africa map connects five national systems without pretending that one regional rule covers them. Saudi Arabia adds SFDA product and establishment checks, Nigeria pairs NAFDAC with PCN verification, and Kenya separates PPB product and facility records.
Regional boundary
One map, distinct national records.
Clinic marketing, wellness language, imported-vial branding, marketplace listings, and direct messages can obscure the legal product identity and responsible supplier. The offer should be routed back to the national product, pharmacy, professional, or establishment records before any comparison.
Verification sequence
Three checks before any regional comparison.
Use the same sequence in every country, while allowing the authority, terminology, available fields, and legal route to change.
Resolve the supplier identity
Check the pharmacy, pharmacist, clinic, professional, manufacturer, importer, or establishment record that applies to the claimed route. Similar branding or a local phone number is not the legal identity.
Read current authority warnings
Review the official safety and enforcement material linked by the country guide. A research label or wellness claim does not cancel statements made by the national medicines authority about unregistered products.
Direct answers
What this regional map can and cannot answer.
These answers preserve the country boundary and point to the source map below. They are not medical or legal advice.
Is there one peptide market rule for the Middle East and Africa?
No. The United Arab Emirates, Saudi Arabia, South Africa, Nigeria, and Kenya use distinct product directories, professional, premises, facility, and establishment records, licensing structures, and enforcement material. Verification must follow the destination country.
Can a clinic or wellness listing be treated as proof that the peptide product is registered?
No. A clinic identity and a product registration answer separate questions. Match the exact product in the national record and independently verify the responsible professional, pharmacy, facility, importer, or supplier where applicable.
Does this regional page recommend where to buy peptides?
No. It provides a regulator-first route for checking claims. Peptide Local does not publish a regional seller ranking without comparable evidence for product category, legal identity, delivery market, current price, and source date.
Tracked compound routes
41 peptide records, one country boundary.
These direct answers resolve the identity and status lane first. Select a destination country before drawing any conclusion about authorization, supply, or a seller.
KPV in Middle East and Africa
KPV in Middle East and Africa is tracked as an FDA-reviewed unapproved peptide identity with preclinical evidence and no identified human administration study. This is not a region-wide authorization, availability, benefit, safety, or supply finding. Choose a destination country and verify its exact product and seller records.
BPC-157 in Middle East and Africa
BPC-157 in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
TB-500 in Middle East and Africa
TB-500 in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
GHK-Cu in Middle East and Africa
GHK-Cu in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Semax in Middle East and Africa
Semax in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Melanotan II in Middle East and Africa
Melanotan II in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
MOTS-c in Middle East and Africa
MOTS-c in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Tesamorelin in Middle East and Africa
Tesamorelin in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
AOD-9604 in Middle East and Africa
AOD-9604 in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Ipamorelin in Middle East and Africa
Ipamorelin in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Selank in Middle East and Africa
Selank in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
PT-141 / Bremelanotide in Middle East and Africa
PT-141 / Bremelanotide in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
CJC-1295 no DAC in Middle East and Africa
CJC-1295 no DAC in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
CJC-1295 DAC in Middle East and Africa
CJC-1295 DAC in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Retatrutide in Middle East and Africa
Retatrutide in Middle East and Africa refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Mazdutide in Middle East and Africa
Mazdutide has NMPA approvals in China, not a region-wide or worldwide approval for Middle East and Africa. Verify the destination country's current product and seller records before treating any offer as authorized or available.
Ecnoglutide in Middle East and Africa
Ecnoglutide has NMPA approvals in China, not a region-wide or worldwide approval for Middle East and Africa. Verify the destination country's current product and seller records before treating any offer as authorized or available.
Enicepatide in Middle East and Africa
Enicepatide in Middle East and Africa refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Eloralintide in Middle East and Africa
Eloralintide in Middle East and Africa refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Cagrilintide in Middle East and Africa
Cagrilintide in Middle East and Africa refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Petrelintide in Middle East and Africa
Petrelintide in Middle East and Africa refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
CagriSema in Middle East and Africa
CagriSema in Middle East and Africa refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
MariTide in Middle East and Africa
MariTide in Middle East and Africa refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Survodutide in Middle East and Africa
Survodutide in Middle East and Africa refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
VK2735 in Middle East and Africa
VK2735 in Middle East and Africa refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Pemvidutide in Middle East and Africa
Pemvidutide in Middle East and Africa refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Amycretin / Zenagamtide in Middle East and Africa
Amycretin / Zenagamtide in Middle East and Africa refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Tirzepatide in Middle East and Africa
Tirzepatide in Middle East and Africa begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.
Orforglipron / Foundayo in Middle East and Africa
Orforglipron / Foundayo in Middle East and Africa begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.
Semaglutide in Middle East and Africa
Semaglutide has product-specific approvals in some jurisdictions, not one transferable worldwide authorization for Middle East and Africa. Verify the exact brand, indication, presentation, prescription route, market status, and seller in the destination country.
DSIP / Emideltide in Middle East and Africa
DSIP / Emideltide in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
IGF-1 LR3 in Middle East and Africa
IGF-1 LR3 in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Kisspeptin-10 / KP-10 in Middle East and Africa
Kisspeptin-10 / KP-10 in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Melanotan I in Middle East and Africa
Melanotan I in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
NAD+ in Middle East and Africa
NAD+ in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Sermorelin in Middle East and Africa
Sermorelin in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Thymosin Alpha-1 in Middle East and Africa
Thymosin Alpha-1 in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
EGRIFTA WR in Middle East and Africa
EGRIFTA WR in Middle East and Africa begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.
Liraglutide in Middle East and Africa
Liraglutide in Middle East and Africa begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.
SCENESSE in Middle East and Africa
SCENESSE in Middle East and Africa begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.
VYLEESI in Middle East and Africa
VYLEESI in Middle East and Africa begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.
Country record map
5 destinations, each with its own source trail.
Open the first source for the product question and the second source for the seller, pharmacy, establishment, or supply question. Read the full country guide for the exact boundary.
01فحص المنتج المسجل والمنشأة المرخصة
الببتيدات في الإمارات العربية المتحدة
العربية · 18 يوليو 2026دليل إماراتي لفحص دليل المنتجات الطبية المسجلة لدى مؤسسة الإمارات للدواء، وترخيص الصيدلي والمنشأة لدى وزارة الصحة ووقاية المجتمع، ومسار التوريد الدقيق وراء أي عرض متعلق بالببتيدات قبل مقارنة السعر أو التوفر.
- Comparison mode
- درهم إماراتي / سجلات المنتج والترخيص الرسمية
- Current price coverage
- لا يوجد جدول مؤهل لبائعي الإمارات
Product recordدليل المنتجات الطبية المسجلة لدى مؤسسة الإمارات للدواءمؤسسة الإمارات للدواء ↗Seller or supply recordترخيص الصيادلةوزارة الصحة ووقاية المجتمع الإماراتية ↗
Read the الإمارات العربية المتحدة guide →02يلزم فحص المنتج والمنشأة لدى هيئة الغذاء والدواء
الببتيدات في المملكة العربية السعودية
العربية · 18 يوليو 2026دليل سعودي لفحص ادعاءات منتجات الببتيدات وإنقاص الوزن في قائمة الأدوية وسجل المنشآت المرخصة لدى الهيئة العامة للغذاء والدواء قبل تقييم التوفر أو السعر أو المورد.
- Comparison mode
- ريال سعودي / سجلات الدواء والمنشأة لدى الهيئة
- Current price coverage
- لا يوجد جدول مؤهل لبائعي السعودية
Product recordقائمة الأدويةالهيئة العامة للغذاء والدواء ↗Seller or supply recordقائمة المنشآت المرخصةالهيئة العامة للغذاء والدواء ↗
Read the المملكة العربية السعودية guide →03Peptide-specific SAHPRA warning
Peptides in South Africa
English · July 18, 2026A South Africa guide to checking peptide offers against SAHPRA's current public warning, registered-medicine directory, and licensed-establishment records.
- Comparison mode
- ZAR / SAHPRA product and establishment records
- Current price coverage
- No qualified South Africa seller table
Product recordMedicines Online DirectorySouth African Health Products Regulatory Authority ↗Seller or supply recordPharmaceutical establishment licensingSouth African Health Products Regulatory Authority ↗
Read the South Africa guide →04NAFDAC product and PCN premises checks required
Peptides in Nigeria
English · July 18, 2026A Nigeria guide to resolving peptide-related product claims in the NAFDAC Greenbook and verifying the pharmacist or pharmaceutical premises through the Pharmacy Council of Nigeria before comparing a seller or supply route.
- Comparison mode
- NGN / NAFDAC product and PCN premises records
- Current price coverage
- No qualified Nigeria seller table
Product recordNAFDAC Greenbook registered product databaseNational Agency for Food and Drug Administration and Control ↗Seller or supply recordPharmacist and premises verificationPharmacy Council of Nigeria ↗
Read the Nigeria guide →05PPB product and facility checks required
Peptides in Kenya
English · July 18, 2026A Kenya guide to checking peptide-related product claims in the Pharmacy and Poisons Board product register and matching the responsible retail, wholesale, hospital, or manufacturing facility in the public licence register.
- Comparison mode
- KES / PPB product and facility records
- Current price coverage
- No qualified Kenya seller table
Product recordPublic pharmaceutical products registerKenya Pharmacy and Poisons Board ↗Seller or supply recordPublic facilities licence registerKenya Pharmacy and Poisons Board ↗
Read the Kenya guide →Publishing gate
No region-wide seller table yet.
Peptide Local will publish regional commercial comparisons only when every row has a sourced seller category, product status, destination market, comparable price, evidence route, and observation date. The current page compares official verification paths.